Paltusotine’s Phase 3 PATHFNDR Program in Acromegaly and Phase 2 Program in Carcinoid Syndrome Remain on Track for Top-Line Data in 2023
Recommendation and review posted by Fredricko
Search Immortality Topics: |
Posted: August 13, 2022 at 1:57 am
Paltusotine’s Phase 3 PATHFNDR Program in Acromegaly and Phase 2 Program in Carcinoid Syndrome Remain on Track for Top-Line Data in 2023
Recommendation and review posted by Fredricko